Of note, one of the CD47-blocking antibody that reduced tumor growth (clone miap410; Willingham et al., 2012b) raised doubts as to its ability to block CD47:SIRPα interaction (Han et al., 2000; Willingham et al., 2012b). Here, SIRPA is linked to neoplasm.